Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis
Sofia Spampinato, Lars Fokdal, Richard Pötter, Christine Haie-Méder, Jacob Christian Lindegaard, Maximilian Schmid, Alina Sturdza, Ina M. Jürgenliemk‐Schulz, Umesh Mahantshetty, Barbara Šegedin, Kjersti Bruheim, Peter Hoskin, Bhavana Rai, Fleur Huang, Rachel Cooper, Elzbieta van der Steen-Banasik, Erik Van Limbergen, Marit Sundset, Henrike Westerveld, Remi A. Nout, Nina Boje Kibsgaard Jensen, Christian Kirisits, Kathrin Kirchheiner, Kari Tanderup
Topics & Concepts
MedicineCervical cancerIncidence (geometry)Persistence (discontinuity)Urinary incontinenceUrologyBladder cancerOncologyCancerInternal medicinePhysicsOpticsGeotechnical engineeringEngineeringEndometrial and Cervical Cancer TreatmentsProstate Cancer Diagnosis and TreatmentCancer survivorship and care